clinical trial · NCT06915246
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
LymphomaNon-Hodgkin LymphomaHodgkin LymphomaVI-0609BiCNU
brief summary
A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.
started
Mar 12, 2025
primary completion
Mar 31, 2027
completion
Apr 30, 2027
last updated
Mar 27, 2026
official title
A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol